This work is licensed under a Creative Commons Attribution 4.0 International License.
ANS-2
General Information
DCTPep ID DCTPep01835
Peptide Name ANS-2
Sequence AVPSPPPAS
Sequence Length 9
UniProt ID Not available
PubChem CID Not available
Origin Synthetics
Type Synthetic peptide
Classification
ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity HaCaT, NHDF: Almost no toxicity to normal cells (fig. 8)
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C37H59N9O12
Absent amino acids CDEFGHIKLMNQRTWY
Theoretical pI 5.57
Acidic residues 0
Basic residues 0
Polar residues 2
Molecular weight (Average) 821.93
Molecular weight (Monoisotopic) 821.43
Common amino acids P
Net charge 0
Instability index (II) 164.71
Aliphatic index 54.44
Grand average of hydropathicity (GRAVY) -0.022
Half Life
4.4 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Extinction coefficients
Should not be visible by UV spectrophotometry.
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID WO2021/025352A1
Patent Title Anticancer Virus Expressing Fgf2- or Api5-Derived Peptide, and Use Thereof
Other Iinformation Patent Application; Family: 3s / 3ex; Family Jurisdictions: WO, KR; Legal Status: Pending; Application No: 2020009856; Filed: Jul 27, 2020; Published: Feb 11, 2021; Earliest Priority: Aug 8, 2019
Other Published ID KR102241134B1 KR20210017560A
This work is licensed under a Creative Commons Attribution 4.0 International License.